跳至主要内容
临床试验/EUCTR2008-006451-52-GB
EUCTR2008-006451-52-GB进行中(未招募)1 期

An investigation of the association between vitamin K intake, vitamin K epoxide reductase subunit (VKORC1) genotype and anticoagulation response to warfarin - How do vitamin K intake and VKOR genotype affect oral anticoagulation?

ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 600 人开始时间: 2009年2月27日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patient being on warfarin for 9 months or more (so that percentage time in target range over the previous 6 months is not affected by the induction period of therapy where the correct maintenance dose is being established), and a target INR of 2.5.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Starting or stopping medication during the 6 months prior to study entry that might have interfered with warfarin, or having an illness during this time which might have affected warfarin dose, or having issues known to result in compliance with warfarin therapy being unreliable.

研究者

发起方
ewcastle upon Tyne Hospitals NHS Foundation Trust

相似试验